Free Trial

Cognition Therapeutics (CGTX) News Today

Cognition Therapeutics logo
$0.46 -0.03 (-6.23%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$0.46 +0.01 (+1.24%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Cognition to Reveal Biomarker Findings Next Week
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
Cognition Therapeutics reports FY24 EPS (86c), consensus (74c)
Cognition Therapeutics (CGTX) to Release Earnings on Thursday
Cognition Therapeutics publishes research on zervimesine in dry AMD
Cognition announces publication of zervimesine manufacturing process
Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
Cognition Therapeutics announces results in Phase 2 study of CT1812
Cognition Therapeutics Reports Promising Q3 2024 Results
Cognition Therapeutics sees cash runway into 2Q25
Remove Ads
Get Cognition Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter.

CGTX Media Mentions By Week

CGTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGTX
News Sentiment

0.05

0.79

Average
Medical
News Sentiment

CGTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGTX Articles
This Week

19

2

CGTX Articles
Average Week

Remove Ads
Get Cognition Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CGTX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners